Underutilization of hepatitis C-positive kidneys for hepatitis c-positive recipients

American Journal of Transplantation

Volumn 10, Issue 5, 2010, Pages 1238-1246

  Kucirka, L M ^a   Singer, A L ^a   Ros, R L ^a   Montgomery, R A ^a   Dagher, N N ^a   Segev, D L ^a,b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Access; Deceased donor transplantation; HCV; Organ utilization; Waiting time

Indexed keywords

ADULT; AFRICAN AMERICAN; AGE; AGED; ARTICLE; CADAVER KIDNEY; CONTROLLED STUDY; DONOR SELECTION; ETHNIC DIFFERENCE; EVIDENCE BASED MEDICINE; FEMALE; GRAFT FAILURE; GRAFT RECIPIENT; GRAFT SURVIVAL; HEALTH CARE UTILIZATION; HEPATITIS C; HUMAN; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK BENEFIT ANALYSIS; SENSITIZATION; SEX DIFFERENCE;

AFRICAN AMERICANS; FEMALE; HEPACIVIRUS; HEPATITIS C; HUMANS; KIDNEY; RISK ASSESSMENT; TISSUE DONORS;

EID: 77951215404     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2010.03091.x     Document Type: Article

References (31)

1. Kalantar-Zadeh K, Kilpatrick RD, McAllister CJ et al. Hepatitis C virus and death risk in hemodialysis patients. J Am Soc Nephrol 2007 18 : 1584 1593. (Pubitemid 46717526)
2. Berenguer M. Treatment of chronic hepatitis C in hemodialysis patients. Hepatology 2008 48 : 1690 1699.
3. Butt AA, Skanderson M, McGinnis KA et al. Impact of hepatitis C virus infection and other comorbidities on survival in patients on dialysis. J Viral Hepat 2007 14 : 688 696. (Pubitemid 47414929)
4. Wang SM, Liu JH, Chou CY, Huang CC, Shih CM, Chen W. Mortality in hepatitis C-positive patients treated with peritoneal dialysis. Perit Dial Int 2008 28 : 183 187. (Pubitemid 351552403)
5. Bucci JR, Matsumoto CS, Swanson SJ et al. Donor hepatitis C seropositivity: Clinical correlates and effect on early graft and patient survival in adult cadaveric kidney transplantation. J Am Soc Nephrol 2002 13 : 2974 2982.
6. Pereira BJ, Wright TL, Schmid CH et al. Screening and confirmatory testing of cadaver organ donors for hepatitis C virus infection: A U.S. National Collaborative Study. Kidney Int 1994 46 : 886 892.
7. Roth D, Fernandez JA, Babischkin S et al. Detection of hepatitis C virus infection among cadaver organ donors: Evidence for low transmission of disease. Ann Intern Med 1992 117 : 470 475.
8. Abbott KC, Lentine KL, Bucci JR et al. Impact of diabetes and hepatitis after kidney transplantation on patients who are affected by hepatitis C virus. J Am Soc Nephrol 2004 15 : 3166 3174.
9. Baid-Agrawal SF, U; Reinke P, Schindler R et al. Impaired insulin sensitivity as an underlying mechanism linking hepatitis c and posttransplant diabetes mellitus in kidney recipients. Am J Transplant 2009 9 : 2777 2784.
10. Batty DS, Jr., Swanson SJ, Kirk AD, Ko CW, Agodoa LY, Abbott KC. Hepatitis C virus seropositivity at the time of renal transplantation in the United States: Associated factors and patient survival. Am J Transplant 2001 1 : 179 184.
11. Bloom RD, Rao V, Weng F, Grossman RA, Cohen D, Mange KC. Association of hepatitis C with posttransplant diabetes in renal transplant patients on tacrolimus. J Am Soc Nephrol 2002 13 : 1374 1380. (Pubitemid 34441419)
12. Fabrizi F, Messa P, Martin P, Takkouche B. Hepatitis C virus infection and post-transplant diabetes mellitus among renal transplant patients: A meta-analysis. Int J Artif Organs 2008 31 : 675 682.
13. Pereira BJ, Wright TL, Schmid CH, Levey AS. A controlled study of hepatitis C transmission by organ transplantation. The New England Organ Bank Hepatitis C Study Group. Lancet 1995 345 : 484 487.
14. Knoll GA, Tankersley MR, Lee JY, Julian BA, Curtis JJ. The impact of renal transplantation on survival in hepatitis C-positive end-stage renal disease patients. Am J Kidney Dis 1997 29 : 608 614. (Pubitemid 27155284)
15. Sezer S, Ozdemir FN, Akcay A, Arat Z, Boyacioglu S, Haberal M. Renal transplantation offers a better survival in HCV-infected ESRD patients. Clin Transplant 2004 18 : 619 623. (Pubitemid 39264364)
16. Bloom RD, Sayer G, Fa K, Constantinescu S, Abt P, Reddy KR. Outcome of hepatitis C virus-infected kidney transplant candidates who remain on the waiting list. Am J Transplant 2005 5 : 139 144. (Pubitemid 40095138)
17. Pereira BJ, Milford EL, Kirkman RL, Levey AS. Transmission of hepatitis C virus by organ transplantation. N Engl J Med 1991 325 : 454 460.
18. Pereira BJ, Milford EL, Kirkman RL et al. Prevalence of hepatitis C virus RNA in organ donors positive for hepatitis C antibody and in the recipients of their organs. N Engl J Med 1992 327 : 910 915.
19. Kiberd BA. Should hepatitis C-infected kidneys be transplanted in the United States? Transplantation 1994 57 : 1068 1072.
20. Bucci JR, Lentine KL, Agodoa LY, Peters TG, Schnitzler MA, Abbott KC. Outcomes associated with recipient and donor hepatitis C serology status after kidney transplantation in the United States: analysis of the USRDS/UNOS database. Clin Transpl 2004 : 51 61.
21. Merion RM, Ashby VB, Wolfe RA et al. Deceased-donor characteristics and the survival benefit of kidney transplantation. JAMA 2005 294 : 2726 2733. (Pubitemid 41770102)
22. Abbott KC, Lentine KL, Bucci JR, Agodoa LY, Peters TG, Schnitzler MA. The impact of transplantation with deceased donor hepatitis c-positive kidneys on survival in wait-listed long-term dialysis patients. Am J Transplant 2004 4 : 2032 2037.
23. Mandal AK, Kraus ES, Samaniego M et al. Shorter waiting times for hepatitis C virus seropositive recipients of cadaveric renal allografts from hepatitis C virus seropositive donors. Clin Transplant 2000 14 (4 Pt 2 391 396. (Pubitemid 30497148)
24. Zou G. A modified poisson regression approach to prospective studies with binary data. Am J Epidemiol 2004 159 : 702 706. (Pubitemid 38405384)
25. USRDS. Annual Data Report http://www.usrds.org/2009/pdf/V2-07-09.PDF. In., 2009.
26. Medicare. Hospital conditions of participation: Requirements for approval and re-approval of transplant centers to perform organ transplantation. Final Rule. In: Fed Regist, 2007 : 15198 15280.
27. Abecassis MM, Burke R, Klintmalm GB et al. American society of transplant surgeons transplant center outcomes requirements-a threat to innovation. Am J Transplant 2009 9 : 1279 1286.
28. Fabrizi F, Messa P, Martin P. Current status of renal transplantation from HCV-positive donors. Int J Artif Organs 2009 32 : 251 261.
29. Rendina M, Schena A, Castellaneta NM et al. The treatment of chronic hepatitis C with peginterferon alfa-2a (40 kDa) plus ribavirin in haemodialysed patients awaiting renal transplant. J Hepatol 2007 46 : 768 774. (Pubitemid 46529043)
30. Carriero D, Fabrizi F, Uriel AJ, Park J, Martin P, Dieterich DT. Treatment of dialysis patients with chronic hepatitis C using pegylated interferon and low-dose ribavirin. Int J Artif Organs 2008 31 : 295 302. (Pubitemid 351890659)
31. Natov SN, Lau JY, Ruthazer R, Schmid CH, Levey AS, Pereira BJ. Hepatitis C virus genotype does not affect patient survival among renal transplant candidates. The New England Organ Bank Hepatitis C Study Group. Kidney Int 1999 56 : 700 706.